ArticleCureus2025
Pre-eclampsia Complicated by HELLP Syndrome in a Primigravida: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Control of HELLP syndrome and pre-eclampsia with microbiota.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pre-eclampsia is a hypertensive disorder of pregnancy that can rapidly progress to HELLP syndrome, increasing maternal and fetal risks. We report a case of a 33-year-old primigravida at 28+1 weeks gestation who presented with severe hypertension, proteinuria, and reduced fetal movements. Despite initial management, she developed progressive thrombocytopenia, worsening liver function, and oligohydramnios, necessitating close monitoring. Biochemical markers indicated worsening disease, prompting an emergency cesarean section at 28+6 weeks, delivering a growth-restricted neonate. Postoperatively, the patient showed gradual improvement, and histopathology confirmed placental malperfusion. This case underscores the importance of early recognition, biochemical monitoring, and timely delivery in managing severe pre-eclampsia and preventing life-threatening complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.